Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fred K Friedman

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Frontiers in Bioscience : a Journal and Virtual Library|September 9, 2004
Molecular modeling of mammalian cytochrome P450sFred K Friedman, Richard C Robinson, Renke Dai
The Protein Journal|June 18, 2004
An effector peptide from glutathione-S-transferase-pi strongly and selectively blocks mitotic signaling by oncogenic ras-p21Lyndon Chie, Victor Adler, Fred K Friedman, et al.
The Protein Journal|June 18, 2004
Loop domain peptides from the SOS ras-guanine nucleotide exchange protein, identified from molecular dynamics calculations, strongly inhibit ras signalingLyndon Chie, Fred K Friedman, Thomas Duncan, et al.
Biochemistry|December 21, 2006
Rapid conformational dynamics of cytochrome P450 2E1 in a natural biological membrane environmentStanley V Smith, Richard C Robinson, Tina G Smith, et al.
The Protein Journal|June 18, 2004
Comparison of molecular dynamics averaged structures for complexes of normal and oncogenic ras-p21 with SOS nucleotide exchange protein, containing computed conformations for three crystallographically undefined domains, suggests a potential role of these domains in ras signalingThomas Duncan, James M Chen, Fred K Friedman, et al.
Journal of Protein Chemistry|September 11, 2002
Comparison of the average structures, from molecular dynamics, of complexes of GTPase activating protein (GAP) with oncogenic and wild-type ras-p21: identification of potential effector domainsJames M Chen, Fred K Friedman, Paul W Brandt-Rauf, et al.
Journal of Protein Chemistry|September 11, 2002
Identification of the site of inhibition of mitogenic signaling by oncogenic ras-p21 by a ras effector peptideLyndon Chie, Fred K Friedman, Hsiang-Fu Kung, et al.
Journal of Protein Chemistry|September 11, 2002
Inhibition of ras-induced oocyte maturation by peptides from ras-p21 and GTPase activating protein (GAP) identified as being effector domains from molecular dynamics calculationsFred K Friedman, Lyndon Chie, Denise Chung, et al.
Cancer Chemotherapy and Pharmacology|December 11, 2007
Two peptides derived from ras-p21 induce either phenotypic reversion or tumor cell necrosis of ras-transformed human cancer cellsVictor Adler, Wilbur Bowne, Ikram Kamran, et al.
British Journal of Pharmacology|May 25, 2002
Arginine to lysine 108 substitution in recombinant CYP1A2 abolishes methoxyresorufin metabolism in lymphoblastoid cellsNicholas E Hadjokas, Renke Dai, Fred K Friedman, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Frontiers in Bioscience : a Journal and Virtual Library|September 9, 2004
Molecular modeling of mammalian cytochrome P450sFred K Friedman, Richard C Robinson, Renke Dai
The Protein Journal|June 18, 2004
An effector peptide from glutathione-S-transferase-pi strongly and selectively blocks mitotic signaling by oncogenic ras-p21Lyndon Chie, Victor Adler, Fred K Friedman, et al.
The Protein Journal|June 18, 2004
Loop domain peptides from the SOS ras-guanine nucleotide exchange protein, identified from molecular dynamics calculations, strongly inhibit ras signalingLyndon Chie, Fred K Friedman, Thomas Duncan, et al.
Biochemistry|December 21, 2006
Rapid conformational dynamics of cytochrome P450 2E1 in a natural biological membrane environmentStanley V Smith, Richard C Robinson, Tina G Smith, et al.
The Protein Journal|June 18, 2004
Comparison of molecular dynamics averaged structures for complexes of normal and oncogenic ras-p21 with SOS nucleotide exchange protein, containing computed conformations for three crystallographically undefined domains, suggests a potential role of these domains in ras signalingThomas Duncan, James M Chen, Fred K Friedman, et al.
Journal of Protein Chemistry|September 11, 2002
Comparison of the average structures, from molecular dynamics, of complexes of GTPase activating protein (GAP) with oncogenic and wild-type ras-p21: identification of potential effector domainsJames M Chen, Fred K Friedman, Paul W Brandt-Rauf, et al.
Journal of Protein Chemistry|September 11, 2002
Identification of the site of inhibition of mitogenic signaling by oncogenic ras-p21 by a ras effector peptideLyndon Chie, Fred K Friedman, Hsiang-Fu Kung, et al.
Journal of Protein Chemistry|September 11, 2002
Inhibition of ras-induced oocyte maturation by peptides from ras-p21 and GTPase activating protein (GAP) identified as being effector domains from molecular dynamics calculationsFred K Friedman, Lyndon Chie, Denise Chung, et al.
Cancer Chemotherapy and Pharmacology|December 11, 2007
Two peptides derived from ras-p21 induce either phenotypic reversion or tumor cell necrosis of ras-transformed human cancer cellsVictor Adler, Wilbur Bowne, Ikram Kamran, et al.
British Journal of Pharmacology|May 25, 2002
Arginine to lysine 108 substitution in recombinant CYP1A2 abolishes methoxyresorufin metabolism in lymphoblastoid cellsNicholas E Hadjokas, Renke Dai, Fred K Friedman, et al.
Pageof 2